Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-15

Clinical Trial Update: Effect of Exenatide on Liver and Heart Fat and Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of Exenatide on liver and heart fat and inflammation in type 2 diabetes; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2016-04-15